(1)
2020 Consensus Guideline for Optimal Approach to the Diagnosis and Treatment of HER2-Positive Breast Cancer in Bosnia and Herzegovina. Biomol Biomed 2021, 21 (2), 120-135. https://doi.org/10.17305/bjbms.2020.4846.